Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Combined modality treatment of newly diagnosed glioblastoma multiforme in a regional neurosurgical centre
Journal of Clinical Neuroscience, 08/03/09
Gauden AJ et al. - Study demonstrates that patients with glioblastoma multiforme (GBM) undergoing maximal resection of the tumour followed by adjuvant radiotherapy and chemotherapy have an improved survival compared to patients undergoing either subtotal resection or biopsy alone; this survival benefit was achieved in a regional neurosurgical centre with minimal additional toxicity.
Methods- Study examines the “local experience” of the Stupp protocol in the treatment of pts with newly diagnosed GBM
- Particular emphasis was given to the extent of surgical resection and its effect on survival
- 31 pts who underwent combined modality treatment according to the Stupp protocol were assessed retrospectively
- Variables assessed were:
- Extent of surgery
- Size and site of the tumour
- Age and performance status
- Primary end points: overall survival (OS) and progression-free survival (PFS)
- Median OS was:
- 33 mo for macroscopic tumour resection (9 pts; 29%)
- 15 mo for debulking (15; 48%), and
- 9 mo for biopsy (7; 22%)
- Macroscopic tumour resection resulted in improved OS and PFS vs 2 less radical surgical options
Related Articles
Distribution, cellular localization, and therapeutic potential of the tumor-associated antigen Ku70/80 in glioblastoma multiforme
Journal of Neuro-Oncology, 10/28/09
Relevance Score: 68%
Antiglioma Immunological Memory in Response to Conditional Cytotoxic/Immune-Stimulatory Gene Therapy: Humoral and Cellular Immunity Lead to Tumor Regression
Clinical Cancer Research, 10/06/09
Relevance Score: 68%
Multiple extracranial metastases from secondary glioblastoma multiforme: a case report and review of the literature
Journal of Neuro-Oncology, 11/18/09
Relevance Score: 67%
Phase II study of fixed dose rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma multiforme
Cancer Chemotherapy and Pharmacology, 10/27/09
Relevance Score: 67%
Phase II Study of Neoadjuvant Imatinib in Glioblastoma: Evaluation of Clinical and Molecular Effects of the Treatment
Clinical Cancer Research, 10/01/09
Relevance Score: 67%
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Intrinsic Gene Expression Profiles of Gliomas Are a Better Predictor of Survival than Histology
Cancer Research, 12/11/09
Glioblastoma Proto-oncogene SEC61gamma Is Required for Tumor Cell Survival and Response to Endoplasmic Reticulum Stress
Cancer Research, 12/11/09
Time Trends in Brain Tumor Incidence Rates in Denmark, Finland, Norway, and Sweden, 1974–2003
Journal of the National Cancer Institute, 12/10/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinical Benefit of Allogeneic Melanoma Cell Lysate–Pulsed Autologous Dendritic Cell Vaccine in MAGE-Positive Colorectal Cancer Patients
Clinical Cancer Research, 12/11/09
Radiation Therapy for Rectal Cancer: Current Status and Future Directions
Cancer Control, 12/11/09
Current Progress in Targeted Therapy for Colorectal Cancer
Cancer Control, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


